Head of Clinic of Infectious Diseases and Dermatovenerology
Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania, Lithuania
L.Jancoriene graduated from Vilnius University Medical faculty in 1989 and finished her residency in gastroenterology in 1993. During her PhD studies she got clinical training in infectious diseases in Karolinska Institutet, Stockholm, Sweden (1999-2003). In 2003 she defended her thesis in field of treatment of chronic hepatitis C. In 2004 she received license for medical practice in infectious diseases and gastroenterology. She attended the postgraduate courses on Travellers’ Health held in Swiss Tropical Institute in Basel, Swiss; course on Hepatology in Hepatobiliary school, Ljubljana, Slovenia; Zalcburg – Cornell Seminars on Infectious Diseases in Salzburg, Austria and international exchange program on CHC, in the University of Pennsylvania, Philadelphia, USA.
She was involved in the coordinating committee of the Lithuanian consensus process of management of CHC and HIV infection. She is member of the steering group for the development of a National Viral Hepatitis Strategy. She has been co-principal and principal investigator in more than 35 clinical trials in treatment and prophylaxis of viral hepatitis B and C, influenza and adult vaccination.
Since 2017, professor L.Jancoriene is a head of the Clinic of Infectious Diseases and Dermatovenerology at the Institute of Clinical Medicine, Medical Faculty, Vilnius University, as well as head of the Infectious Diseases Center in Vilnius University Hospital Santaros klinikos. Since the beginning of the COVID-19 pandemic, she has participated in the Expert Group under the Government of Lithuania and was a member of the Council of Health Experts established by the President of Lithuania. As head of the Center for Infectious Diseases, she worked at the epicenter of the COVID-19 pandemic, building a skilled team of specialists, actively involved in the pandemic management process. Since 2020, more than 10 national and international biomedical studies on COVID-19 have been initiated under her leadership, with results published in international medical journals.